New schemes
We actively follow the development of laboratory medicine as we want to produce clinically relevant EQA schemes to serve clinical laboratories and point-of-care sites. We launch new pilot studies on a regular basis and aim to increase our Labquality EQAS by Aurevia portfolio with 5-10 new EQA schemes every year.
Planned pilot studies for 2025
We are now proudly launching this year's first pilot studies, which will be conducted starting in March. Registration for these pilots is open and will close on 24 February 2025. More information and registration links are found below. The arranged pilots will be free of charge for a limited number of participants.
This year, we also include a short survey in the pilot studies. By responding, you can give us important information on how we can make the EQA scheme better for you.
Bacterial vaginosis and vaginitis multiplex, nucleic acid detection
Labquality EQAS by Aurevia is introducing a new EQA scheme for bacterial vaginosis and vaginitis multiplex, nucleic acid detection by arranging a pilot study free of charge for a limited number of participants.
Please register by 24 February 2025.
Gram stain, vaginal fluid
Labquality EQAS by Aurevia is introducing a new EQA scheme for Gram stain, vaginal fluid by arranging a pilot study free of charge for a limited number of participants.
Please register by 24 February 2025.
HPV-associated head and neck cancer
Labquality EQAS by Aurevia is introducing a new EQA scheme for Human papillomavirus (HPV) -associated head and neck cancer by arranging a pilot study free of charge for a limited number of participants.
Please register by 24 February 2025.
Human Erythropoietin and Thrombopoietin
Labquality EQAS by Aurevia is introducing a new EQA scheme for human Erythropoietin and Thrombopoietin by arranging a pilot study free of charge for a limited number of participants.
Please register by 24 February 2025.
Immunosuppressants
Labquality EQAS by Aurevia is introducing a new EQA scheme for immunosuppressive drugs including ciclosporin, tacrolimus, sirolimus and everolimus, by arranging a pilot study free of charge for a limited number of participants.
Please register by 24 February 2025.
All planned pilot studies for 2025/2026
Bacteriology: Gram stain, vaginal fluid
Clinical Chemistry: Immunosuppressants
Clinical Chemistry: Human Erythropoietin and Thrombopoietin
Clinical Chemistry: Neurofilament, light chains
Clinical Chemistry: EQA for Microsampling techniques
Parasitology: Leishmania, nucleic acid detection
Virology: West Nile virus, antibody detection
Virology: HPV-associated head and neck cancer
EQA for molecular pathology
Veterinary EQA
Recently performed pilot studies
Holotranscobalamin (HoloTC) and Methylmalonic Acid
Check the up-to-date round schedules in the latest product catalogue.
Norovirus, antigen detection
Check the up-to-date round schedules in the latest product catalogue.
Helicobacter pylori, nucleic acid detection
Check the up-to-date round schedules in the latest product catalogue.
Maternal serum screening
Check the up-to-date round schedules in the latest product catalogue.
Mycoplasma genitalium, drug resistance multiplex, nucleic acid detection
Check the up-to-date round schedules in the latest product catalogue.
Pipette control
Check the up-to-date round schedules in the latest product catalogue.
Salivary Cortisol
Check the up-to-date round schedules in the latest product catalogue.
Chemokine CXCL13
Check the up-to-date round schedules in the latest product catalogue.
Interferon Gamma Release Assay (IGRA) for Mycobacterium tuberculosis
Check the up-to-date round schedules in the latest product catalogue.
Faecal Elastase
Check the up-to-date round schedules in the latest product catalogue.
Fungal infections, nucleic acid detection
Check the up-to-date round schedules in the latest product catalogue.
Mycobacterium tuberculosis, rifampicin and isoniazid, nucleic acid detection
Check the up-to-date round schedules in the latest product catalogue.
Adrenocorticothropic hormone ACTH and Cortisol
Check the up-to-date round schedules in the latest product catalogue.
HSV1&2 / VZV / T. pallidum, nucleic acid detection
Check the up-to-date round schedules in the latest product catalogue.
EQA for next-generation sequencing methods
We are developing external quality assessments for NGS methods in microbiology. If you are interested, please contact us!
Contact us for more information!

Heidi Berghäll

Kristel Virtanen
Explore our services

EQA Product Catalogue
Our external quality assessment service program includes more than 250 quality assessment schemes, covering all specialities of laboratory medicine. Furthermore, the program includes an extensive selection of services designed for medical laboratories and point-of-care testing sites.
.jpg)
Integrated EQA Service
.jpg)
New EQA Schemes

Digital External Quality Assessment Programs
Our digital EQA product line provides an advanced approach to external quality assessment. Digital EQA programs or virtual EQA programs use digital images, videos, virtual microscopy technology, and questionnaires as EQA samples.
Latest news

Introducing Aurevia


Patient Safety: The Cornerstone of Healthcare

